Showing results (81-90 of 190) with videos related to

Sort By:
Pageof 19
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 18, 2014
Report of a phase I evaluation of dose and schedule of interleukin-1 alpha and cyclophosphamide in patients with advanced tumors: An Eastern Cooperative Oncology Group study (PX990) and review of IL-1-based studies of hematopoietic reconstitutionJanice P Dutcher, Donna Neuberg, Michael B Atkins, et al.
Investigational New Drugs|January 7, 2004
Phase II study of interferon gamma in malignant carcinoid tumors (E9292): a trial of the Eastern Cooperative Oncology GroupKeith Stuart, Donna E Levy, Tom Anderson, et al.
Medical Oncology (Northwood, London, England)|August 20, 2005
Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-Hodgkin's lymphomaJoseph A Sparano, Abdissa Negassa, Erick Lansigan, et al.
Medical Oncology (Northwood, London, England)|February 21, 2009
Effect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologiesJanice P Dutcher, Paul de Souza, David McDermott, et al.
Cancer Medicine|August 18, 2021
Adherence to oral therapies among patients with renal cell carcinoma: Post hoc analysis of the ECOG-ACRIN E2805 trialCaitlin C Murphy, Hannah M Fullington, David E Gerber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2011
Drug-related pneumonitis in patients with advanced renal cell carcinoma treated with temsirolimusJose Pablo Maroto, Gary Hudes, Janice P Dutcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinomaBrian I Rini, George Wilding, Gary Hudes, et al.
Pageof 19